PAB 16.7% 0.7¢ patrys limited

Ann: PAT-DX1 Conjugated to Nanoparticles, Targets Tumors, page-122

  1. 35,718 Posts.
    lightbulb Created with Sketch. 552
    It's interesting, sure. Still very early stage pre-clinical in the lab, basically in petri dishes. Maybe try further again and into mice next year ? Along with the other proposed mouse models in 2018. FWIW when ever people are banging on about "cure for cancer" is more hurt than good imo - and in petri-dishes that's not anything new, plenty of people / companies can cure cancer in a petri dish or test tube. PARP inhibitors are a hot space although we already knew that and they thought they would work synergistically with inhibitors like parp.

    Further animal models should be interesting in 2018
 
watchlist Created with Sketch. Add PAB (ASX) to my watchlist
(20min delay)
Last
0.7¢
Change
0.001(16.7%)
Mkt cap ! $14.40M
Open High Low Value Volume
0.7¢ 0.7¢ 0.7¢ $490 70K

Buyers (Bids)

No. Vol. Price($)
19 5911085 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 1726399 6
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
PAB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.